Solutions

Online Inquiry

* Your Name

Phone Number

* E-mail Address

* Services Interested

Project Description

Please note that we are a research service provider, not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Clinical Research Services

Ophthalmic disease drug clinical research is the systematic scientific evaluation of therapeutic interventions targeting eye and visual system disorders through rigorously designed studies to establish safety, efficacy, and optimal dosing for ocular drug development. Protheragen provides professional, scientific, and compliant support for ophthalmic drug clinical research services, including IIT and IST design, execution, data management, statistical analysis, and medical writing.

Overview of Ophthalmic Disease Drug Clinical Research

Ophthalmic disease drug clinical research represents a specialized, evidence-driven scientific discipline dedicated to evaluating the safety, tolerability, pharmacokinetic properties, pharmacodynamic responses, and therapeutic efficacy of pharmaceutical interventions designed to prevent, manage, or reverse vision-threatening disorders. This branch of clinical investigation operates at the intersection of ocular anatomy, molecular pharmacology, visual neuroscience, and regulatory science, with the core mission of translating laboratory-validated molecules into clinically accessible therapies that preserve and restore visual function.

The duration of clinical development for novel therapeutics, categorized by therapeutic area and molecular modality.

Fig.1 Clinical development times for innovative drugs as a function of therapeutic class and molecule type. (Brown D. G., et al., 2022)

Unlike systemic drug development, ophthalmic research must account for unique biological constraints: the blood-ocular barrier, limited intraocular volume, sensitive ocular tissues, and distinct pharmacokinetic profiles of topically administered, intraocular, and periocular formulations. Common indications under investigation include age-related macular degeneration, diabetic retinopathy, glaucoma, dry eye disease, uveitis, inherited retinal dystrophies, corneal dystrophies, and inflammatory ocular conditions.

Key Methodological Challenges in Ophthalmic Clinical Research

Ophthalmic trials face unique methodological challenges that require specialized design solutions. Ocular drug delivery limitations often result in low bioavailability, particularly for posterior segment diseases, requiring highly potent formulations and targeted delivery systems that increase complexity of safety testing.

Standardization of ophthalmic assessments demands rigorous training and centralized reading processes to reduce inter‑observer variability, as subtle changes in visual function or retinal structure can determine trial outcomes. Patient recruitment is hindered by low prevalence of rare retinal diseases and geographically dispersed patient populations.

Protocol complexity increases due to specialized requirements for sterile compounding, temperature‑controlled product storage, and administration techniques unique to intraocular therapies. Regulatory stringency is heightened for ophthalmic products, with detailed expectations for stability, sterility, pH, osmolarity, and preservative content.

Our Services

Protheragen delivers comprehensive end-to-end clinical research services for ophthalmic drug development, encompassing strategic protocol design, regulatory navigation, clinical operations, data management, and biostatistical analysis for both Investigator Initiated Trials and Industry Sponsored Trials, with specialized expertise in navigating the unique anatomical, physiological, and regulatory complexities of ocular therapeutics.

One-stop Solution for Clinical Research

Investigator Initiated Trial (IIT) Services

Strategic Study Design and Protocol Development

Expert consultation to transform clinical research questions into rigorous, scientifically sound protocols with optimized study endpoints and statistical frameworks tailored to ophthalmic disease characteristics.

Comprehensive Regulatory Navigation

End-to-end regulatory support including institutional review board (IRB) and ethics committee (EC) submission preparation, regulatory authority correspondence, and compliance monitoring throughout the study lifecycle.

Feasibility Assessment and Site Selection

Systematic evaluation of potential research sites based on patient population availability, investigator experience, equipment capabilities, and historical recruitment performance to ensure study viability.

Clinical Trial Coordination Office Establishment

Setup and operational support for dedicated research coordination centers, including infrastructure planning, personnel training, and implementation of standardized operating procedures.

Patient Recruitment and Enrollment Management

Development of targeted recruitment strategies, pre-screening logistics, and enrollment tracking systems to achieve timely patient accrual while maintaining protocol eligibility criteria.

Electronic Data Capture and Management

Configuration and deployment of electronic data capture (EDC) systems, case report form (CRF) design, data validation programming, and ongoing database maintenance for high-quality data collection.

Biostatistical Planning and Analysis

Development of statistical analysis plans, randomization schema design, interim analysis support, and comprehensive statistical reporting for scientific publications and regulatory submissions.

Safety Monitoring and Reporting

Establishment of safety data collection processes, adverse event assessment workflows, and periodic safety reporting to ensure participant protection and regulatory compliance.

Central Laboratory Coordination

Management of laboratory logistics including specimen collection kits, shipping logistics, and integration of laboratory data with central databases for seamless data flow.

Publication and Scientific Dissemination Support

Assistance with manuscript preparation, abstract submissions, and presentation development to facilitate timely dissemination of research findings to the scientific community.

Industry Sponsored Trial (IST) Services

By Workflow

Phase I Clinical Trial

First-in-human safety and tolerability assessments conducted in healthy volunteers or patients to establish initial safety profiles, dose-ranging parameters, and pharmacokinetic characteristics of novel ophthalmic therapeutics.

Phase II Clinical Trial

Exploratory efficacy and safety evaluations in target patient populations to determine proof-of-concept, refine dosing regimens, and identify optimal endpoints for subsequent pivotal studies.

Phase III Clinical Trial

Large-scale confirmatory studies designed to demonstrate statistically significant efficacy and comprehensive safety profiles to support regulatory marketing authorization applications.

Phase IV Clinical Trial

Post-marketing surveillance and effectiveness studies conducted to evaluate long-term safety, rare adverse events, and real-world clinical outcomes in broader patient populations.

By Management

Integrated Project Management
Centralized oversight of all trial activities through dedicated project managers who coordinate cross-functional teams, maintain timelines, and ensure alignment with sponsor objectives and regulatory requirements.
Risk-Based Quality Management
Implementation of risk assessment frameworks and targeted monitoring strategies to identify, mitigate, and manage potential risks to data integrity and patient safety throughout the trial duration.
Regulatory Strategy and Submissions
Strategic planning for global regulatory pathways, preparation of investigational new drug (IND) applications, and management of regulatory authority interactions and correspondence.
Clinical Monitoring and Site Oversight
Remote and centralized monitoring activities including data verification, protocol compliance assessment, and site performance evaluation to ensure GCP adherence and data quality.
Data Management and Biometrics
Comprehensive data services encompassing database design, data cleaning, coding, quality control, statistical programming, and analysis dataset preparation for regulatory submissions.

Medical Monitoring and Safety Surveillance
Continuous medical oversight including eligibility review, protocol deviation assessment, safety data evaluation, and medical query resolution to protect participant welfare.
Vendor and Supplier Management
Coordination of third-party service providers including central laboratories, imaging core laboratories, and technology vendors to ensure seamless integration and performance accountability.
Technology and Systems Integration
Deployment and maintenance of clinical trial management systems (CTMS), electronic data capture platforms, and randomization systems to support efficient trial operations.
Budget and Contract Management
Development of study budgets, negotiation of site contracts, and ongoing financial tracking to ensure cost-effective trial execution within approved budget parameters.
Quality Assurance and Auditing
Systematic quality review processes including internal audits, vendor audits, and readiness assessments for regulatory inspections to ensure compliance with ICH-GCP standards.

Disease Areas of Focus

Drawing on proven expertise in ophthalmic drug development, Protheragen delivers comprehensive clinical research solutions designed around your therapeutic modality. From diagnostics and therapy development to disease modeling, safety evaluation, and pharmacokinetic studies, we provide the integrated scientific support to accelerate your program from concept to clinic. Contact us today to discuss how our integrated solutions can advance your specific development needs.

Reference

Brown, Dean G., et al. "Clinical development times for innovative drugs." Nat Rev Drug Discov 21.11 (2022): 793-794.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.